Abstract
OXA-72 has been reported in few countries around the world. We report the first case in Colombia in an Acinetobacter pittii clinical isolate. The arrival of a new OXA, into a country with high endemic resistance, poses a significant threat, especially because the potential for widespread dissemination is considerable.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Acinetobacter / drug effects
-
Acinetobacter / enzymology*
-
Anti-Bacterial Agents / pharmacology
-
Bacterial Proteins / genetics
-
Bacterial Proteins / metabolism*
-
Colombia
-
Microbial Sensitivity Tests
-
beta-Lactamases / genetics
-
beta-Lactamases / metabolism*
Substances
-
Anti-Bacterial Agents
-
Bacterial Proteins
-
beta-Lactamases
-
carbapenemase